Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug
Author(s):
Meijer, E.; Gansevoort, R.T.; Jong, P.E. de; Wal, A.M. van der; Leonhard, W.N.; Krey, S.R. de; Born, J. van den; Mulder, G.M.; Goor, H. van; Struck, J.; Heer, E. de; Peters, D.J.M. (0000-0001-6974-7143)
